Unibios Holdings (ATH:BIOSK) Beta: 1.0243 (As of Jul. 04, 2026)


ATH:BIOSK Unibios Holdings SA ATH:BIOSK
64 GF Score
Price €2.65
GF Value €1.47
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Unibios Holdings Beta?

Unibios Holdings ATH:BIOSK -0.38% 64 Beta is 1.0243 as of Jul. 04, 2026. GuruFocus rates ATH:BIOSK with a GF Score™ of 64/100 and a GF Value™ of €1.47 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-04), Unibios Holdings's Beta is 1.0243.


Unibios Holdings  (ATH:BIOSK) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Unibios Holdings Beta Related Terms


Unibios Holdings Beta Historical Data

* Premium members only.

The historical data trend for Unibios Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unibios Holdings Beta Chart

Unibios Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 1.01 1.09 1.17 1.12

Unibios Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.25 1.17 1.05 1.12

ATH:BIOSK vs VLTO, ZWS, CECO: Beta Comparison

For the Pollution & Treatment Controls subindustry, Unibios Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unibios Holdings Beta vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Unibios Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Unibios Holdings's Beta falls into.


ATH:BIOSK
64GF Score
Unibios Holdings SA ATH:BIOSK
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unibios Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.0243 mean?
Unibios Holdings (ATH:BIOSK) has a Beta of 1.0243 as of Jul. 04, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Unibios Holdings and its competitors.
Is Unibios Holdings' Beta too high?
Unibios Holdings' current Beta is 1.0243. Overall, Unibios Holdings has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' Beta compare to VLTO and ZWS?
Unibios Holdings' Beta of 1.0243 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Industrial Products company?
A good Beta depends on the Industrial Products industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Unibios Holdings and its competitors. Unibios Holdings's current Beta is 1.0243. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.47, compared to a current price of €2.65 — trading 80.3% above its estimated fair value. The current Beta is 1.0243. Unibios Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current Beta is 1.0243 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?

Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued. The current stock price of €2.65 is trading 80.3% above its estimated GF Value™ of €1.47. GuruFocus considers Unibios Holdings to be Significantly Overvalued.

Key valuation signals for ATH:BIOSK:

  • Beta: 1.0243
  • GF Value™: €1.47 vs. price of €2.65 (80.3% above fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Unibios Holdings Business Description

Other Exchanges BEXQ:Germany
Address 1st and 18th Street, Ano Liosia, GRC, 13341
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
64GF Score

Get the complete analysis for ATH:BIOSK

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.65
Price
€1.47
GF Value